Contact:
James A. Deye, Ph.D.
Radiation Research Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
Telephone: (301) 496 6111
E-mail: deyej@mail.nih

Objective of Project:

The overall purpose of this RFA is to facilitate and support NCI-sponsored clinical trials which employ advanced technology radiotherapy methods, particularly those requiring digital data submission. To accomplish this overall goal, the Division of Cancer Treatment and Diagnosis, National Cancer Insitute (NCI) has established the Advanced Technology Radiation Therapy Clinical Trials Support (ATC) consortium. The funding mechanism will be the U24 collaborative agreement resource mechanism.

Description of Project:

Through this initiative, the NCI will ensure safe and effective clinical trials by promoting:

1. Uniform quality assurance (QA) standards as part of all complex conformal radiation therapy (RT) trials;
2. Increased cooperation among the clinical trial QA efforts especially in the area of uniform credentialing and benchmarking of facility capabilities;
3. Increased implementation of DICOM RT data exchange standards including vendor-specific capabilities;
4. Increased uniformity in archival and database methodologies so that data mining relative to patient outcomes may be realized, and
5. Further development of phantoms to test the efficacy and quality of proposed complex treatment methodologies.

Funds Set Aside:

The funds set aside for this grant are $1,750,000 Total Cost for the first year with a maximum 5 year award.